Literature DB >> 15613029

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

J Liu1, T I Pestina, M C Berndt, S A Steward, C W Jackson, T K Gartner.   

Abstract

BACKGROUND: Binding of von Willebrand factor (VWF) to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates a cascade of events leading to alphaIIbbeta3 activation and platelet aggregation. The roles of ADP and thromboxane A2 (TXA2) in agglutination-induced GPIbalpha-mediated platelet activation have not been fully described.
METHODS: Botrocetin and human VWF were used to stimulate washed mouse platelets. Platelets deficient in TXA2 receptors, Galphaq, or alphaIIbbeta3, and inhibitors and chelating agents were used to investigate the roles of TXA2, ADP, alphaIIbbeta3 and Ca2+ in botrocetin/VWF-induced signaling.
RESULTS: Our data demonstrate that botrocetin/VWF/GPIbalpha-mediated agglutination results in calcium-independent protein kinase C (PKC) and phospholipase A2 (PLA2) activities required for GPIbalpha-elicited TXA2 production that in turn causes dense granule secretion. Aggregation of washed platelets requires TXA2-induced alphaIIbbeta3 activation and ADP signaling. TXA2 or ADP can activate alphaIIbbeta3, but both are required for alpha-granule secretion and aggregation. Botrocetin/VWF-induced dense granule secretion is Galphaq-dependent. alpha-Granule secretion requires initial ADP signaling through P2Y1 and subsequent signaling through P2Y12. Signaling initiated by agglutination is propagated and amplified in an alphaIIbbeta3-dependent manner.
CONCLUSIONS: In contrast to adhesion or shear stress-induced GPIb-elicited signaling, agglutination-elicited GPIb signaling that activates alphaIIbbeta3 requires TXA2. Agglutination-elicited TXA2 production is independent of Ca2+ influx and mobilization of internal Ca2+ stores. Therefore, our results demonstrate that agglutination-elicited GPIb signaling causes alphaIIbbeta3 activation by a mechanism that is distinct from those used by adhesion, or shear stress-induced GPIb signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613029     DOI: 10.1111/j.1538-7836.2004.01023.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  21 in total

1.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Authors:  Yosuke Okamura; Makoto Handa; Hidenori Suzuki; Yasuo Ikeda; Shinji Takeoka
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

3.  Bernard-Soulier syndrome.

Authors:  Michael C Berndt; Robert K Andrews
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

4.  The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.

Authors:  M Keegan Delaney; Junling Liu; Yi Zheng; Michael C Berndt; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

5.  Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo.

Authors:  Junling Liu; Malinda E Fitzgerald; Michael C Berndt; Carl W Jackson; T Kent Gartner
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

6.  LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.

Authors:  Brian Estevez; Aleksandra Stojanovic-Terpo; M Keegan Delaney; Kelly A O'Brien; Michael C Berndt; Changgeng Ruan; Xiaoping Du
Journal:  Blood       Date:  2013-04-25       Impact factor: 22.113

7.  Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

Authors:  Haruhiko Tokuda; Gen Kuroyanagi; Takashi Onuma; Yukiko Enomoto; Tomoaki Doi; Hiroki Iida; Takanobu Otsuka; Shinji Ogura; Toru Iwama; Kumi Kojima; Osamu Kozawa
Journal:  Biomed Rep       Date:  2018-02-06

8.  A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex.

Authors:  Fi-Tjen Mu; Robert K Andrews; Jane F Arthur; Adam D Munday; Susan L Cranmer; Shaun P Jackson; Frank C Stomski; Angel F Lopez; Michael C Berndt
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

9.  The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.

Authors:  Hong Yin; Aleksandra Stojanovic; Nissim Hay; Xiaoping Du
Journal:  Blood       Date:  2007-10-03       Impact factor: 22.113

10.  Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF.

Authors:  Rhishikesh Thakare; Yashpal S Chhonker; Nagsen Gautam; Amy Nelson; Richard Casaburi; Gerard Criner; Mark T Dransfield; Barry Make; Kendra K Schmid; Stephen I Rennard; Yazen Alnouti
Journal:  Biomed Chromatogr       Date:  2017-10-17       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.